RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 PEGASUS-TIMI 54 Subanalysis
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 28
SP 20
OP 21
DO 10.1177/1559897715611881
UL http://mdc.sagepub.com/content/15/28/20.abstract
AB The PEGASUS-TIMI 54 trial demonstrated that continuing treatment with ticagrelor after 1 year following myocardial infarction protected patients from ischemic events and provided a more robust risk reduction compared to reinitiation in stable patients on aspirin monotherapy. Patients who were treated with only aspirin for > 1year after myocardial infarction did not derive any benefit from reinitiation of P2Y12 inhibitor therapy and had an increased risk of bleeding.